Staff

Progyny and RESOLVE to Launch National Infertility Awareness Week® by Ringing the Nasdaq Stock Market Opening Bell and Lighting the Empire State Building

The fertility benefits leader and national infertility nonprofit association take over the capital of the world to support the millions...

SCYNEXIS Secures Additional Commercial Insurance Formulary Coverage for BREXAFEMME® (ibrexafungerp tablets), Providing Access to an Estimated 93 Million Commercially-Insured Lives

Advanced first-in-class, one-day oral antifungal treatment, BREXAFEMME is now covered for approximately 55 percent of commercially-insured U.S. patientsJERSEY CITY, N.J.,...

error: Content is protected !!